Harvey talks about the Benjamins

  • by: |
  • 11/24/2007
Harvey Bale (IFPMA) responds to a recent letter in The Lancet accusing some patient groups of conflict of interest.

Thai MoH's undeclared interest: its profit-making pharma operation

The letter published in the last edition of The Lancet under the title "WHO's web-based public hearings: hijacked by pharma?" expresses surprise that patient groups could advocate "pro-IP" views in internet submissions ahead of last week's WHO Inter Governmental Working Group. It goes on to imply this could only have happened because of the "pharmaceutical industry compromising patient advocacy groups".

If the authors of the paper seek to present this as an issue, it is because they are firmly on the "anti-IP" side of the IGWG debate, but the authors conclude their letter by declaring that they have no conflict of interest.

The first author listed is Suwit Wilbulpolprasert, who correctly presents himself as an employee of the Ministry of Health, Nonthaburi, Thailand. The Thai Ministry of Health owns the Government Pharmaceutical Organization (GPO), the role of which is to manufacture and import medicines and sell them for profit.(1) The GPO made a net profit of one billion baht ($30.8 million) on revenues of 5 billion baht ($154.1 million) in 2005, according to former deputy health minister Anuthin Charnveerakul.(2)

The compulsory licenses that the Thai MoH has issued in the last year allow the GPO to import and sell for profit generic copies of two antiretrovirals and one cardiovascular medicine still under patent. This move raised an international furor and the Thai MoH has so far refrained from implementing its publicly stated intention to implement further compulsory licenses. Any outcome of the WHO IGWG which endorses expanded use of compulsory licensing would support the Thai MoH in issuing more such licenses and so help GPO to increase its profit-making activities. Dr. Wilbulpolprasert's declaration of no conflict of interest does not hold up.

I declare the following interests: I head the international R&D-based pharmaceutical industry association, which believes that adequate intellectual property protection is an essential prerequisite for innovation in medicines and the improvement of global health outcomes. The R&D pharmaceutical industry also believes that patients' voices should be heard in discussions about health policy, and is prepared to contribute financially to help permit this, while accepting that patient groups are free to express their own opinions, even when these might be critical of the industry.

Yours sincerely,

Dr. Harvey Bale

Director General
International Federation of Pharmaceutical Manufacturers & Associations

For more on this issue, see our November 16th blog entry, "Compulsory Hypocrisy" here:


As H.L. Mencken once said, when someone says it isn't about money, it's about money.

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog